Clinical Trials Browser

Phase 1/2 × Burkitt Lymphoma × forodesine × Clear all

NCT00289562 2012-01-20

Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia

Phase 1/2 Completed

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Lymphoma